The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies
Mohamed E. Shaker, Ahmed A. Shaaban, Mohamed El‐Shafey, Mohamed El‐Mesery
Topics & Concepts
CardiotoxicityDoxorubicinPharmacologyNephrotoxicityIn vivoChemistryCisplatinApoptosisToxicityOxidative stressMedicineChemotherapyBiochemistryBiologyInternal medicineOrganic chemistryBiotechnologyChemotherapy-induced cardiotoxicity and mitigationChemotherapy-induced organ toxicity mitigationLiver physiology and pathology